Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Suppressing ODC activity reduces tumor growth in hair follicles.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

Shaving and applying erythromycin cream and clotrimazole powder effectively treated trichomycosis axillaris.

A woman with a rare scalp infection was cured after one month of medication.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Combining UV therapy with PRP heals chronic wounds faster and reduces pain.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Men are increasingly getting botulinum toxin treatments, requiring higher doses and different techniques than women for a natural look.

A woman had a rare infection of both white piedra and head lice, which improved after 10 weeks of antifungal treatment.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PUVA-therapy is not very effective for severe hair loss types like alopecia totalis or universalis.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

New treatments for lupus show promise, but more research is needed, especially for children.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.